IFN-γ, as a key immune regulatory cytokine, plays a crucial role in anti-tumor immunity [78], and thus, lung cancer cells' modulation of neutrophils to reduce IFN-γ secretion might be part of their immune evasion strategy. The gene discussed is IFNG; the disease is neoplasm.